XTL Biopharmaceuticals Ltd. (XTLB)
NASDAQ: XTLB · Real-Time Price · USD
0.7750
+0.0103 (1.35%)
At close: Mar 3, 2026, 4:00 PM EST
0.7740
-0.0010 (-0.13%)
After-hours: Mar 3, 2026, 7:33 PM EST
XTL Biopharmaceuticals Market Cap
XTL Biopharmaceuticals has a market cap or net worth of $6.13 million as of March 3, 2026. Its market cap has decreased by -72.68% in one year.
Market Cap
6.13M
Enterprise Value
5.94M
1-Year Change
-72.68%
Ranking
Category
Stock Price
$0.78
Market Cap Chart
Since August 31, 2005, XTL Biopharmaceuticals's market cap has decreased from $179.98M to $6.13M, a decrease of -96.59%. That is a compound annual growth rate of -15.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 6.13M | -13.95% |
| Dec 31, 2025 | 7.12M | -68.18% |
| Dec 31, 2024 | 22.38M | 322.69% |
| Dec 31, 2023 | 5.30M | -16.54% |
| Dec 29, 2022 | 6.35M | -57.67% |
| Dec 30, 2021 | 14.99M | -4.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Theriva Biologics | 7.13M |
| Alaunos Therapeutics | 7.12M |
| Quoin Pharmaceuticals | 7.02M |
| Quince Therapeutics | 7.00M |
| Aspire Biopharma Holdings | 6.98M |
| BiomX | 6.96M |
| Immuron | 6.49M |
| Aprea Therapeutics | 6.41M |